The underwriters in the offering will have a 30-day option to purchase up to an additional 571,038 shares of common stock from the Company at the public offering price, less underwriting discounts and commissions. 

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. 

The Company will not receive any of the proceeds from the sale of shares of the Company's common stock by the Selling Stockholder.